Skip to content

Clinical trials

Phase 1 Breast Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1 Country / region: Belgium Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20051
20062
20073
20083
20092
20101
20112
20122
20138
20151
20165
20172
20185
20193
20201
20212
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Active, not recruiting5
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
Eli Lilly and Company6
Genentech, Inc.4
Jules Bordet Institute4
AstraZeneca2
GlaxoSmithKline2
Pfizer2
ADC Therapeutics S.A.1
Amgen1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms49
Neoplasm Metastasis7
Colorectal Neoplasms6
Neoplasms6
Triple Negative Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Pancreatic Neoplasms4
Stomach Neoplasms4
Melanoma3
Ovarian Neoplasms3

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.